Skip to content
★ Sign in to follow
GF

George Fred Wilkinson

CEO
Impax Laboratories, LLCWatson Pharmaceuticals IncAllergan plc
Total declarations
29
Companies
3
▲ Purchases (0 ops.)
—
▼ Sales (4 ops.)
€5.4M

Latest filing published 23 Dec 2016 for Impax Laboratories, LLC, €2.9M.

Insider track record

Disclosed buys
0
Disclosed sells
4
Signal history

George Fred Wilkinson: trading record in brief

Filings by George Fred Wilkinson span 3 companies, the busiest being Watson Pharmaceuticals Inc, Impax Laboratories, LLC and Allergan plc. We count 29 filings; the first trade dates from 21 September 2009 and the latest from 29 April 2016.

Every open-market trade on record is a sale: 4 sales worth €5.4M. Outside the open market, there are 24 share grants.

The latest filing, published on 23 December 2016, reports a share grant of €2.9M in Impax Laboratories, LLC. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to George Fred Wilkinson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations29 total

25 of 29 declarations